Evidence map›Paper›PMID 40160035›Full record

ArticleThe international journal of neuropsychopharmacology2025

Sedative and hypnotic effects of nuciferine: enhancing rodent sleep via serotonergic system modulation.

Luo-Xuan Wang, Yu-Meng Liu, Yong-Fang Gu, Lu Li, Ren-Hong Qiu, Yan-Kai Wang, Jin Yang, Ji Wang, Yang Zhang, Shuo Li and 4 more

Abstract read
In one paragraph

Article in The international journal of neuropsychopharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Luo-Xuan WangBeijing Institute of Pharmacology and Toxicology, Beijing 100850, China.
Yu-Meng LiuBeijing Institute of Pharmacology and Toxicology, Beijing 100850, China.
Yong-Fang GuBeijing Institute of Pharmacology and Toxicology, Beijing 100850, China.
Lu LiBeijing Institute of Pharmacology and Toxicology, Beijing 100850, China.
Ren-Hong QiuBeijing Institute of Pharmacology and Toxicology, Beijing 100850, China.
Yan-Kai WangBeijing Institute of Pharmacology and Toxicology, Beijing 100850, China.
Jin YangBeijing Institute of Pharmacology and Toxicology, Beijing 100850, China.
Ji WangBeijing Institute of Pharmacology and Toxicology, Beijing 100850, China.
Yang ZhangBeijing Institute of Pharmacology and Toxicology, Beijing 100850, China.
Shuo LiBeijing Institute of Pharmacology and Toxicology, Beijing 100850, China.
Qiong-Yin FanBeijing Institute of Pharmacology and Toxicology, Beijing 100850, China.
Rui XueBeijing Institute of Pharmacology and Toxicology, Beijing 100850, China.
Jing-Cao LiBeijing Institute of Pharmacology and Toxicology, Beijing 100850, China.
You-Zhi ZhangBeijing Institute of Pharmacology and Toxicology, Beijing 100850, China.ORCID 0000-0002-1686-8651

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInsomnia is the most prevalent sleep disorder globally. Nuciferine (NF), a bioactive constituent extracted from Nelumbo nucifera leaves, is recognized for its diverse pharmacological activities. However, its sleep-regulating effects have not been investigated. This study aimed to delineate the therapeutic effects and underlying mechanisms of NF in mitigating insomnia.

methodsThe sedative-hypnotic effects of NF were assessed employing locomotor activity test, pentobarbital-induced sleep test, and electroencephalography-based sleep profiling. Insomnia symptoms in rodents were induced by serotonin (5-HT) depletion and environmental stress. The potential mechanisms of NF's action through the regulation of central serotonin system were also explored.

resultsNuciferine attenuated locomotor activity and extended pentobarbital-induced sleep duration in a dose-dependent manner. It also significantly augmented total and non-rapid eye movement (NREM) sleep time and enhanced delta power at frequencies of 0.5 and 1 Hz in normal rats. Sleep analysis revealed that NF effectively reversed the reduction in total and NREM sleep time caused by environmental stress from cage changing. NF treatment also proved effective against insomnia induced by 5-HT depletion, as evidenced by increased sleep duration and reduced sleep latency. Further investigation revealed a synergetic effect of NF and 5-hydroxytryptophan, alone with increased 5-HT and 5-HT1A receptor levels in the hypothalamus of insomniac mice following NF administration.

conclusionsThe results demonstrate NF's hypnotic effects and its ability to alleviate insomnia, providing preclinical evidence for its potential as a naturally derived treatment for insomnia.

Indexed as

Hypnotics and SedativesSerotoninSleepSleep Initiation and Maintenance DisordersAnimalsAporphinesDisease Models, AnimalElectroencephalographyMaleMiceRatsRats, Sprague-DawleyReceptor, Serotonin, 5-HT1AAporphinesHypnotics and SedativesnuciferineReceptor, Serotonin, 5-HT1ASerotoninEEGinsomnianuciferinesedative-hypnotic

Identifiers

PMID40160035
PMCPMC12084828

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.